ACVR1 and fibrodysplasia ossificans progressiva: Approximately 97% of individuals with FOP carry a gain-of-function mutation (c.617G > A; R206H) in the glycine-serine domain of ACVR1 [7], which results in enhanced BMP pathway signalling [8].